McKesson Corp (N:MCK)

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEC
Company Contact
Address: 6555 State Highway 161
IRVING TX 75039
Tel: N/A
Website: https://www.mckesson.com
IR: See website
<
Key People
Brian Scott Tyler
Chief Executive Officer, Director
Britt J. Vitalone
Chief Financial Officer, Executive Vice President
Leann B. Smith
Chief Human Resource Officer, Executive Vice President
Francisco Fraga
Executive Vice President, Chief Technology Officer, Chief Information Officer
Michele Lau
Executive Vice President, Chief Legal Officer
Tom L. Rodgers
Executive Vice President, Chief Strategy and Business Development Officer
Business Overview
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.
Financial Overview
For the nine months ended 31 December 2023, McKesson Corp revenues increased 12% to $232.6B. Net income before extraordinary items decreased 20% to $2.21B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by U.S. Pharmaceutical segment income decrease of 63% to $900M, Medical-Surgical Solutions segment income decrease of 42% to $512M.
Employees: 45,000 as of Mar 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $72,085M as of Dec 31, 2023
Annual revenue (TTM): $301,506M as of Dec 31, 2023
EBITDA (TTM): $4,358M as of Dec 31, 2023
Net annual income (TTM): $2,998M as of Dec 31, 2023
Free cash flow (TTM): $2,584M as of Dec 31, 2023
Net Debt Last Fiscal Year: $3,909M as of Dec 31, 2023
Shares outstanding: 131,408,286 as of Dec 31, 2023
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.